Singh, Asheesh, and Parul Singh. “TERIFLUNOMIDE: A NOVEL ORAL DISEASE-MODIFYING AGENT UNDER INVESTIGATION FOR THE TREATMENT OF MULTIPLE SCLEROSIS”. Journal of Drug Delivery and Therapeutics, vol. 6, no. 5, Sept. 2016, pp. 97-102, https://doi.org/10.22270/jddt.v6i5.1303.